Intrinsic Value of S&P & Nasdaq Contact Us

Agenus Inc. AGEN

NASDAQ Capital Marke

SharesGrow Score
48/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$7.33
+55.3%

Agenus Inc. (AGEN) current share price is $4.72. The gold spot price is $4,825.20 per troy ounce. Using the formula: AGEN in gold = $4.72 × 31.1035 ÷ $4,825.20 = 0.0304 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of AGEN when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding AGEN shares over the measured period.

AGEN in US Dollars
Gold in US Dollars
AGEN in Gold (grams per share)

Real Wealth Growth Rate

AGEN
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{AGEN}_{\text{gold}}(t) = \frac{P_{\text{AGEN}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{AGEN}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{AGEN}_{\text{gold}}^{(T)}}{\text{AGEN}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{AGEN}_\text{gold}^{(0)}$ = initial gold-price, $\text{AGEN}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

MDGL
MDGL
Madrigal Pharmaceuticals, Inc.
$524.99
-0.13%
TGTX
TGTX
TG Therapeutics, Inc.
$34.56
+2.28%
VKTX
VKTX
Viking Therapeutics, Inc.
$35.52
+1.46%
EWTX
EWTX
Edgewise Therapeutics, Inc.
$33.16
-2.01%
ICVX
ICVX
Icosavax, Inc.
$15.31
-0.91%
ADCT
ADCT
ADC Therapeutics SA
$3.86
+1.31%
ADAP
ADAP
Adaptimmune Therapeutics plc
$0.05
-3.00%
PDSB
PDSB
PDS Biotechnology Corporation
$1.06
-2.75%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message